<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-07-07T18:47:43Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/6253" metadataPrefix="mods">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/6253</identifier><datestamp>2024-07-25T07:33:04Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4365</setSpec><setSpec>com_10259_6256</setSpec><setSpec>com_10259_9476</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>col_10259_9477</setSpec><setSpec>col_10259_4366</setSpec><setSpec>col_10259_6257</setSpec><setSpec>col_10259_4364</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Fernández Pampín, Natalia</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Vaquero Gutiérrez, Mónica</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Gil Antón, Tania</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Espino Ordóñez, Gustavo</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Fernández Zoppino, Darío</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>García Ruiz, Begoña</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Busto Vázquez, Natalia</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2021-12-02T09:29:29Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2021-12-02T09:29:29Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2022-01</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="issn">0162-0134</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10259/6253</mods:identifier>
<mods:identifier type="doi">10.1016/j.jinorgbio.2021.111663</mods:identifier>
<mods:abstract>Three neutral Pt(II) complexes containing 1-Methylimidazole and the antifungal imidazolyl drugs Clotrimazole and Bifonazole have been prepared. The general formula of the new derivatives is [Pt(κ2-(C^N)Cl(L)], where C^N stands for ppy = 2-phenylpyridinate, and L = 1-Methylimidazole (MeIm) for [Pt-MeIm]; L = Clotrimazole (CTZ) for [Pt-CTZ] and L = Bifonazole (BFZ) for [Pt-BFZ]). The complexes have been completely characterized in solution and the crystal structures of [Pt-BFZ] and [Pt-CTZ] have been resolved. Complexes [Pt-MeIm] and [Pt-BFZ] present higher cytotoxicity than cisplatin in SW480 (colon adenocarcinoma), A549 (lung adenocarcinoma) and A2780 (ovarian cancer) cell lines. [Pt-MeIm] shows the highest accumulation in A549 cells, in agreement with its inability to interact with serum albumin. By contrast, [Pt-CTZ] and [Pt-BFZ] interact with serum proteins, a fact that reduces their bioavailability. The strongest interaction with bovine serum albumin (BSA) is found for [Pt-BFZ], which is the least internalized inside the cells. All the complexes are able to covalently interact with DNA. The most cytotoxic complexes, [Pt-MeIm] and [Pt-BFZ] induce cellular accumulation in G0/G1 and apoptosis by a similar pathway, probably involving a reactive oxygen species (ROS) generation mechanism. [Pt-BFZ] turns out to be the most efficient complex regarding ROS generation and causes mitochondrial membrane depolarization, whereas [Pt-MeIm] induces the opposite effect, hyperpolarization of the mitochondrial membrane. On the contrary, the least cytotoxic complex, [Pt-CTZ] cannot block the cell cycle or generate ROS and the mechanism by which it induces apoptosis could be a different one.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
<mods:subject>
<mods:topic>Cyclometalated platinum(II) complexes</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Clotrimazole</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Bifonazole</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Reactive oxygen species (ROS)</mods:topic>
</mods:subject>
<mods:subject>
<mods:topic>Antitumoral</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Distinct mechanism of action for antitumoral neutral cyclometalated Pt(II)-complexes bearing antifungal imidazolyl-based drugs</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>